Subtle clues—from handwriting to snoring—can reveal the earliest warnings of illness. Here's how to read your own distress ...

Infliximab biosimilar is under clinical development by Celltrion and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

NO festive gathering is complete without a feast, desserts and plenty of holiday drinks. But while these celebrations are exciting, they can be hard on our stomachs, often leading to that familiar ...

Divine Gol n Win best win percentage cricket captain Takeda's Entyvio SC achieves success in Phase III clinical tri ...

After living with a condition for eight years, most people would learn to understand how it affects their body, but with ...

Researchers have made a major medical breakthrough by developing a vaccine against the crippling digestive illness Crohn's disease. More than 100,000 people in the UK are stricken by the condition ...

Cancer can affect anyone at any age. However, cancer is increasingly prevalent as we age, with most occurrences occurring in those 50 and older. It’s crucial to avoid attributing any odd changes, ...

A study from University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue to experience symptoms, even in the absence of inflammation.

Signs of emotional manipulation may include using the silent treatment, competing, and gaslighting. Some manipulation tactics may be subtle and could leave you wondering if it’s them or if you ...

Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 ...

A similar, roughly 48% of Crohn’s disease patients given a high dose of duvakitug experienced meaningful improvement ... All ...